UGT1A1 and metabolic dysfunction-associated steatotic liver disease: To determine whether our analysis of the association of metabolic ratios with the UGT1A1*28 polymorphism might be confounded by differences due to liver disease types, the mean metabolic ratio, MR(0–48 h), between HCV and NAFLD subjects were compared.